Baker Bros. Advisors’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Hold |
|
|||||
|
2025
Q1 | $2.29M | Hold |
|
|||||
|
2024
Q4 | $2.83M | Hold |
|
|||||
|
2024
Q3 | $982K | Hold |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $801K | Hold |
|
|||||
|
2023
Q4 | $374K | Hold |
|
|||||
|
2023
Q3 | $333K | Hold |
|
|||||
|
2023
Q2 | $477K | Hold |
|
|||||
|
2023
Q1 | $625K | Hold |
|
|||||
|
2022
Q4 | $535K | Hold |
|
|||||
|
2022
Q3 | $591K | Hold |
|
|||||
|
2022
Q2 | $585K | Hold |
|
|||||
|
2022
Q1 | $1.02M | Hold |
|
|||||
|
2021
Q4 | $1.35M | Hold |
|
|||||
|
2021
Q3 | $1.38M | Hold |
|
|||||
|
2021
Q2 | $1.95M | Hold |
|
|||||
|
2021
Q1 | $3.14M | Hold |
|
|||||
|
2020
Q4 | $4.83M | Hold |
|
|||||
|
2020
Q3 | $3.36M | Hold |
|
|||||
|
2020
Q2 | $5.85M | Hold |
|
|||||
|
2020
Q1 | $4.59M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $678K | Hold |
|
|||||
|
2018
Q3 | $582K | Hold |
|
|||||
|
2018
Q2 | $732K | Hold |
|
|||||
|
2018
Q1 | $746K | Hold |
|
|||||
|
2017
Q4 | $567K | Hold |
|
|||||
|
2017
Q3 | $597K | Hold |
|
|||||
|
2017
Q2 | $455K | Hold |
|
|||||
|
2017
Q1 | $523K | Sell |
|
|||||
|
2016
Q4 | $740K | Buy |
|
|||||
|
2016
Q3 | $2.79M | Hold |
|
|||||
|
2016
Q2 | $2.4M | Hold |
|
|||||
|
2016
Q1 | $2.31M | Hold |
|
|||||
|
2015
Q4 | $4.63M | Buy |
|
|||||
|
2015
Q3 | $3.82M | Buy |
|
|||||
|
2015
Q2 | $3.16M | Buy |
|
|||||
|
2015
Q1 | $2.01M | Hold |
|
|||||
|
2014
Q4 | $1.8M | Buy |
|